Logo

    dees

    Explore " dees" with insightful episodes like "Assess the Efficacy and Safety of Emerging Strategies That Impact Brain Cholesterol Turnover", "Brain Cholesterol: The New Landscape of Neurological Disease Management", "Episode 30 | No guest", "Episode 29 | Jake Lever" and "Episode 28 | Hamish Blake" from podcasts like ""CCO Neuroscience Podcast", "CCO Neuroscience Podcast", "Gus & Gawny", "Gus & Gawny" and "Gus & Gawny"" and more!

    Episodes (40)

    Assess the Efficacy and Safety of Emerging Strategies That Impact Brain Cholesterol Turnover

    Assess the Efficacy and Safety of Emerging Strategies That Impact Brain Cholesterol Turnover

    Link to CME: Claim Credit - https://bit.ly/3OByCaE

    In this episode, Drs. Halford and Hahn discuss the current treatment landscape of developmental and epileptic encephalopathies (DEEs), such as Lennox-Gastaut syndrome and Dravet syndrome, and the emerging role of brain cholesterol in addressing seizure frequency. The full episode covers:

    • How to diagnose these epilepsies and the FDA-approved treatment options in the first-line and second-line settings
    • The role of antiseizure medications in DEE treatment management
    • The nonpharmacological treatment options available to patients with DEEs
    • The emerging role of brain cholesterol in neurologic diseases like DEEs and Alzheimer’s disease
    • Results from the ELEKTRA clinical trial, including cholesterol synthase inhibitors’ impact on seizure frequency
    • The future of soticlestat as a treatment option for pediatric patients with DEEs

    Presenters:

    Jonathan J. Halford, MD
    Professor
    Director, Translational Research Unit
    Department of Neurology
    Medical University of South Carolina
    Charleston, SC

    Cecil Hahn, MD, MPH, FRCPC
    Professor
    Pediatric Epileptologist
    University of Toronto
    Toronto, Ontario, Canada

    Content based on an online CME program supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc.

    Link to full program: 
    https://bit.ly/45UUpQy

    Brain Cholesterol: The New Landscape of Neurological Disease Management

    Brain Cholesterol: The New Landscape of Neurological Disease Management

    Link to CME: Claim Credit - https://bit.ly/3wbVkA1

    In this episode, Drs. Halford and White discuss the emerging role of brain cholesterol in the development and potential treatment of neurological diseases like epilepsy or Alzheimer and Huntington diseases. The full episode covers:

    • Overview of brain cholesterol and its function in the body
    • Pathogenesis potential for certain diseases via brain cholesterol
    • Emerging research on a cholesterol synthase inhibitor as a novel therapy
    • The future of soticlestat as a potential treatment option for pediatric epilepsies—Lennox-Gastaut syndrome and Dravet syndrome—and other neurological diseases

    Presenters:

    Jonathan J. Halford, MD
    Professor
    Director, Translational Research Unit
    Department of Neurology
    Medical University of South Carolina
    Charleston, SC

    H. Steve White, PhD
    Professor, Department of Pharmacy
    Co-Director, Center for Epilepsy Drug Discovery
    School of Pharmacy
    University of Washington
    Seattle, Washington

    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io